Post M - Search Results

1

Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution.

Laham RJ, Post M, Rezaee M, Donnell-Fink L, Wykrzykowska JJ, Lee SU, Baim DS, Sellke FW. Laham RJ, et al. Among authors: post m. Drug Metab Dispos. 2005 Aug;33(8):1101-7. doi: 10.1124/dmd.104.002774. Epub 2005 May 6. Drug Metab Dispos. 2005. PMID: 15879496

2

Intrapericardial administration of basic fibroblast growth factor: myocardial and tissue distribution and comparison with intracoronary and intravenous administration.

Laham RJ, Rezaee M, Post M, Xu X, Sellke FW. Laham RJ, et al. Among authors: post m. Catheter Cardiovasc Interv. 2003 Mar;58(3):375-81. doi: 10.1002/ccd.10378. Catheter Cardiovasc Interv. 2003. PMID: 12594706

3

Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.

Laham RJ, Rezaee M, Post M, Sellke FW, Braeckman RA, Hung D, Simons M. Laham RJ, et al. Among authors: post m. Drug Metab Dispos. 1999 Jul;27(7):821-6. Drug Metab Dispos. 1999. PMID: 10383927

4

Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.

Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, Simons M, Hung D. Laham RJ, et al. Among authors: post m. J Pharmacol Exp Ther. 2000 Feb;292(2):795-802. J Pharmacol Exp Ther. 2000. PMID: 10640320

5

Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins.

Laham RJ, Li J, Tofukuji M, Post M, Simons M, Sellke FW. Laham RJ, et al. Among authors: post m. Ann Vasc Surg. 2003 May;17(3):245-52. doi: 10.1007/s10016-001-0299-x. Epub 2003 Apr 22. Ann Vasc Surg. 2003. PMID: 12704544

6

Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein.

Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, Sellke FW. Ruel M, et al. Among authors: post mj. J Thorac Cardiovasc Surg. 2002 Jul;124(1):28-34. doi: 10.1067/mtc.2002.121974. J Thorac Cardiovasc Surg. 2002. PMID: 12091805 Free article. Clinical Trial.

7

Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.

Sato K, Laham RJ, Pearlman JD, Novicki D, Sellke FW, Simons M, Post MJ. Sato K, et al. Among authors: post mj. Ann Thorac Surg. 2000 Dec;70(6):2113-8. doi: 10.1016/s0003-4975(00)02018-x. Ann Thorac Surg. 2000. PMID: 11156130

8

Therapeutic angiogenesis in cardiology using protein formulations.

Post MJ, Laham R, Sellke FW, Simons M. Post MJ, et al. Cardiovasc Res. 2001 Feb 16;49(3):522-31. doi: 10.1016/s0008-6363(00)00216-9. Cardiovasc Res. 2001. PMID: 11166265 Review.

9

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

Sato K, Wu T, Laham RJ, Johnson RB, Douglas P, Li J, Sellke FW, Bunting S, Simons M, Post MJ. Sato K, et al. Among authors: post mj. J Am Coll Cardiol. 2001 Feb;37(2):616-23. doi: 10.1016/s0735-1097(00)01144-x. J Am Coll Cardiol. 2001. PMID: 11216988 Free article.

10

Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization.

Bao J, Naimark W, Palasis M, Laham R, Simons M, Post MJ. Bao J, et al. Among authors: post mj. Catheter Cardiovasc Interv. 2001 Jul;53(3):429-34. doi: 10.1002/ccd.1196. Catheter Cardiovasc Interv. 2001. PMID: 11458429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,673 results

Search Page

Filters